Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis. [electronic resource]
Producer: 20180309Description: 341-352 p. digitalISSN:- 1744-7607
- Animals
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Biological Availability
- Daclizumab
- Dose-Response Relationship, Drug
- Humans
- Immunoglobulin G -- administration & dosage
- Immunosuppressive Agents -- administration & dosage
- Interleukin-2 Receptor alpha Subunit -- immunology
- Magnetic Resonance Imaging
- Medication Adherence
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.